These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3893815)

  • 1. Microthrombus formation on hemodialysis membranes: a placebo controlled randomized trail of two doses of Indobufen.
    Salter MC; Mayor P; Crow MJ; Rajah SM; Davison AM
    Clin Nephrol; 1985 Jul; 24(1):31-6. PubMed ID: 3893815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of indobufen on platelet function and dialyzer regeneration in patients on hemodialysis].
    Sokołowska B; Dmoszyńska A; Janicka L; Walter-Croneck A
    Pol Arch Med Wewn; 1995 Jun; 93(6):475-82. PubMed ID: 7491347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet activity and tolerance of indobufen (K3920) in cerebrovascular disease: a therapeutic approach.
    Carrieri P; Orefice G; La Pia S; Indaco A; D'Acunio F; Iadevaia V
    Pharmatherapeutica; 1983; 3(6):410-6. PubMed ID: 6353432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of platelet deposition and thrombus formation on hemodialysis membranes: a double-blind randomized trial of aspirin and dipyridamole.
    Salter MC; Crow MJ; Donaldson DR; Roberts TG; Rajah SM; Davison AM
    Artif Organs; 1984 Feb; 8(1):57-61. PubMed ID: 6703927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
    Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M
    G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of indobufen on occlusion of arteriovenous fistulas and some platelet activity in intermittent peritoneal dialysis patients.
    Dmoszyńska A; Janicki K; Janicka L; Przesmycki K; Sokołowska B; Walter-Croneck A
    Pol J Pharmacol; 1996; 48(3):327-9. PubMed ID: 9112671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of indobufen on the thrombogenic potential of a Dacron prosthesis in an artificial circulation.
    Sheehan SJ; Monson JR; Salter MC; Rajah DS; Rajah SM; Kester RC
    Eur J Vasc Surg; 1988 Aug; 2(4):223-7. PubMed ID: 2975227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-thromboglobulin and platelet factor 4 plasma levels during haemodialysis: effect of indobufen.
    Pogliani EM; Colombi M; Cristoforetti G; Valenti G; Miradoli R; Buccianti G
    Pharmatherapeutica; 1982; 3(2):127-32. PubMed ID: 6179101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of thromboxane biosynthesis and platelet function by indobufen in type II diabetes mellitus.
    Davì G; Patrono C; Catalano I; Custro N; Giammarresi C; Ganci A; Cosentino F; Notarbartolo A
    Arterioscler Thromb; 1993 Sep; 13(9):1346-9. PubMed ID: 8364018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). A randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests.
    Nenci GG; Berrettini M; Iadevaia V; Parise P; Ballatori E
    Pharmatherapeutica; 1982; 3(3):188-94. PubMed ID: 7134226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term antiplatelet activity and safety of indobufen in patients with cardiovascular disease. Italian Multicenter Study Group.
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):439-46. PubMed ID: 3899952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of aspirin and indobufen in healthy volunteers.
    Lee JY; Sung KC; Choi HI
    Platelets; 2016; 27(2):105-9. PubMed ID: 26083594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology studies with indobufen (K 3920): inhibitor of platelet aggregation.
    Vinazzer H; Fuccella LM
    J Clin Pharmacol; 1980; 20(5-6 Pt 1):316-25. PubMed ID: 7400367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man.
    De Caterina R; Sicari R; Yan A; Bernini W; Giannessi D; Lazzerini G; Efthymiopoulos C; Strolin-Benedetti M
    Thromb Haemost; 1992 Feb; 67(2):258-63. PubMed ID: 1621247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indobufen is a potent inhibitor of whole blood aggregation in patients with a high atherosclerotic risk.
    Mannucci L; Maderna P; Colli S; Lavezzari M; Sirtori CR; Tremoli E
    Thromb Res; 1987 Nov; 48(4):417-26. PubMed ID: 3445229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind placebo-controlled trial of indobufen in the prophylaxis of migraine.
    Carrieri PB; Orefice G; Sorge F
    Acta Neurol Scand; 1988 Jun; 77(6):433-6. PubMed ID: 3043994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indobufen: an updated review of its use in the management of atherothrombosis.
    Bhana N; McClellan KJ
    Drugs Aging; 2001; 18(5):369-88. PubMed ID: 11392445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of 40 K protein phosphorylation in platelet by a new antithrombotic agent, d-indobufen.
    Mamiya S; Hagiwara M; Ishikawa T; Hidaka H
    Thromb Res; 1989 Jun; 54(5):447-56. PubMed ID: 2505401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and ex vivo effects of indobufen on human platelet aggregation, the release reaction and thromboxane B2 production.
    Cattaneo M; Bevilacqua C; Lecchi A; Mannucci PM
    Haemostasis; 1987; 17(5):293-300. PubMed ID: 3666587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study.
    Fornaro G; Rossi P; Mantica PG; Caccia ME; Aralda D; Lavezzari M; Pamparana F; Milanesi G
    Circulation; 1993 Jan; 87(1):162-4. PubMed ID: 8419003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.